| Bristol-Myers Squibb SA - Sprycel 50 mg, Filmtabletten | | 57658 | | 02 | | Sprycel 50 mg | | Filmtabletten | | L01EA02 | | | | 02.02.2007 | | |
| | Composition | | dasatinibum 50 mg ut dasatinibum monohydricum, lactosum monohydricum 67.5 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.56 mg, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Dasatinib | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Dasatinib | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | color. | | | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 67.5 mg | | | Macrogol | 400 | | | | | | | | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 60 Tablet(s) | 2145.50 | 2283.75 | A | SL | No | | 008 | 60 Tablet(s) | PR | PR | A | | Yes |
|
|
